Language selection

Search

Notice of Submission from Monsanto Canada Inc. for Novel Food, Livestock Feed and Environmental Safety Approval for Commercial Planting Purposes of a Plant Genetically Modified For Herbicide Tolerance

Comment period closed: January 23, 2015

Background:

The CFIA and Health Canada have received a submission from Monsanto Canada Inc. seeking an environmental safety approval for commercial planting purposes and livestock feed and food use of a maize line designated as MON 87419, which has been genetically modified to exhibit herbicide tolerance. The submission received is in accordance with CFIA guidelines for assessment of plants with novel traits (PNTs) for unconfined release, CFIA guidelines for assessment of novel feeds from PNTs, and HC guidelines for assessment of novel foods. To view information related to the environmental assessment of a plant with novel traits (PNT) or a novel feed derived from PNTs, please refer to the CFIA Web site. To view the information related to the health and safety assessment of a novel food, please refer to the Health Canada Web site.

Summary of the Submission Package

Updated scientific information may be added to this submission by the developer at a later date, or CFIA and/or Health Canada may request further information from the developer.

Description of the host plant

Please refer to Biology Document BIO 1994-11: The Biology of Zea mays (L.) (Maize).

Description of the Modification

Corn line MON 87419 was developed through the use of recombinant DNA technology. In order to assess the modification process, the following has been submitted:

Inheritance and Stability of the Introduced Trait

In order to assess the inheritance and stability of the genetic modification the following has been submitted:

Description of the Novel Traits

In order to characterize the DNA inserted in the plant, the following has been submitted:

Absence of Toxicity of the Novel Gene Products

The absence of toxicity of the expressed genetic components on non-target species, humans and animals. The following have been either submitted or previously submitted, reviewed, and published:

Nutritional Evaluation of the Novel Plant

In order to assess nutritional aspects of the novel plant the following has been submitted:

Allergenicity/Toxicity Considerations

In order to assess allergenicity and toxicity of the expressed genetic components the following has been submitted:

Evaluation of the Environmental Impact of the Novel Plant

In order to assess the environmental impact of the novel plant the following has been submitted:

For more information on this product, please contact:

Monsanto Canada Inc.
180 Kent Street, Suite 810
Ottawa ON
(613) 234-5121

Date modified: